healthcare-thumbnail.png

Chemotherapy Induced Nausea and Vomiting (CINV) market Research Report

Published: 2025 - January

Report Code: VMR-17742

Region: Global

Request Sample
Customization
Ask an Expert
Enquire Enquire Before Buying

Chemotherapy Induced Nausea and Vomiting (CINV) Market Analysis

The Chemotherapy Induced Nausea and Vomiting (CINV) market refers to the segment of the oncology sector that focuses on the management and treatment of nausea and vomiting induced by chemotherapy agents. These symptoms significantly impact the quality of life for cancer patients and can lead to treatment discontinuation or reduced therapeutic efficacy. CINV is categorized into several types, including acute, delayed, anticipatory, breakthrough, and refractory, each requiring specific therapeutic interventions.

Disruptive Impact and Opportunities:

The CINV market is undergoing a transformation due to the development of next-generation antiemetic drugs and novel delivery methods. Emerging drugs like APD403 and CAM2047 aim to offer more effective, faster-acting solutions with fewer side effects, creating potential game-changers in treatment paradigms. Oral formulations and transdermal patches are simplifying administration, improving patient compliance and convenience. New therapies are designed to reduce adverse effects, offering safer options for patients with sensitive or high-risk profiles. As the prevalence of cancer continues to rise globally, the demand for effective CINV treatments will grow, providing significant market expansion opportunities.

Chemotherapy Induced Nausea and Vomiting (CINV) Market Segmentation: Emerging Drugs

  • APD403

  • CAM2047

Chemotherapy Induced Nausea and Vomiting (CINV) Market Segmentation: Marketed Drugs

  • Olanzapine PO

  • Aloxi (Palonosetron)

  • Zofran Generic (Ondansetron)

  • Kytril Generic (Granisetron)

  • Emend (Aprepitant)

Key Companies:

  • Acacia Pharma

  • Camurus

  • LP Pharmaceuticals

  • Skye Bioscience

  • TALLC Corporation

  • Starton Therapeutics

Chemotherapy Induced Nausea and Vomiting (CINV) Market Segmentation: By Type

  • Acute Chemotherapy-Induced Nausea and Vomiting (CINV)

  • Delayed Chemotherapy-Induced Nausea and Vomiting (CINV)

  • Anticipatory Chemotherapy-Induced Nausea and Vomiting (CINV)

  • Breakthrough Chemotherapy-Induced Nausea and Vomiting (CINV)

  • Refractory Chemotherapy-Induced Nausea and Vomiting (CINV)

Chemotherapy Induced Nausea and Vomiting (CINV) Market Segmentation: By Administration Type

  • Oral

    • Tablets

    • Capsules

    • Liquid Formulations

  • Injectable

    • Intravenous (IV)

    • Subcutaneous (SC)

  • Transdermal

    • Patches

  • Other Delivery Methods

    • Rectal

    • Sublingual

What’s in It for You?

  • In-depth analysis of emerging drugs and their market potential.

  • Insights into key players driving innovation and market share.

  • Strategic recommendations for positioning in the evolving CINV treatment landscape.

  • Market forecasts and trend analyses to help anticipate future opportunities.

  • Understanding of regulatory trends impacting the CINV market, including approval timelines for emerging therapies.

  • Detailed review of competitive dynamics and market entry strategies.

  1. Chemotherapy Induced Nausea and Vomiting Market - Executive Summary

    1. Introduction

    2. Objectives

    3. Key Findings

      1. Market Size 2025 & 2030: By Key Country (10MM)

      2. Global Market Size 2025 & 2030: By Key Segment

      3. Key Investments & Startup Analysis

    4. Research Methodology

  2. Understanding the Disease

    1. Disease Overview

    2. Classification

    3. Signs and Symptoms

    4. Risk Factors

    5. Causes

    6. Disease Biology & Digital Innovations

    7. Stages & Staging System

    8. Diagnostic Algorithm

    9. Current Treatment Practices & Algorithm

    10. Current Standard of Care and Treatment Gaps

    11. Patient Demographics and Treatment Pathways

  3. Guidelines

  4. Unmet Needs

  5. Epidemiology and Patient Population

    1. Epidemiology Key Findings

    2. Assumptions and Rationale: 10MM

    3. Epidemiology Scenario: 10MM

    4. U.S. Epidemiology Scenario

    5. EU-5 Epidemiology

      1. U.K. Epidemiology Scenario

      2. Germany Epidemiology Scenario

      3. France Epidemiology Scenario

      4. Italy Epidemiology Scenario

      5. Spain Epidemiology Scenario

    6. Japan Epidemiology Scenario

    7. China Epidemiology Scenario

    8. Australia Epidemiology Scenario

    9. India Epidemiology Scenario   

  6. Real-world Data & Real-world Evidence

  7. Drug Development Landscape

    1. Existing Key Drug Candidate Profiles/ Marketed Therapies

    2. Competitive Analysis and Differentiation

    3. Overview of Similar/Competing Drugs in Clinical Trials

    4. Future Trends and Emerging Drugs

  8. Regulatory Strategy and Potential Challenges

    1. Regulatory Pathways in Key Markets

    2. Anticipated Regulatory Hurdles and Mitigation Strategies

    3. Case Studies in Oncology Drug Regulation

    4. Impact of Potential Changes to Regulatory Framework

  9. Commercial Landscape

    1. Market Size & Growth Rates

    2. Key Approvals & Anticipated Loss of Exclusivity

    3. PESTLE & Porter’s Five Forces Analysis

    4. Market Shares, Positioning/Ranking

    5. Market Drivers

    6. Identification of Threats

    7. Digital Evolution in Commercialization

  10. Market Segmentation

  11. Pricing, Reimbursement, and Access

    1. Competitive Pricing Analysis

    2. Reimbursement Landscape and Challenges

    3. Strategies for Market Access and Equity

    4. Patient Spending/Expenditure Analysis

  12. Future Trends, Disruptions, and Opportunities

    1. Analysis of Emerging Trends

    2. Technological Impact

    3. Impact of Potential Market Disruptors

    4. Opportunities for Future Development and Expansion

    5. Considerations for Investment Opportunities

  13. Global Market Dynamics

    1. Regional Regulatory Disparities

    2. Cross-Border Partnership Strategies

    3. Global Supply Chain Dynamics

    4. Case Studies: Success and Failure in Global Markets

    5. Strategies for Global Expansion and Localization

  14. Company Profiles

 

 

Download Sample

↻

The field with (*) is required.

Choose License Type

$

2500

$

4250

$

5250

$

6900

Request Sample
Customization
Ask an Expert
Enquire Before Buying
customer-support

Analyst Support

Every order comes with Analyst Support.

report-custom

Customization

We offer customization to cater your needs to fullest.

verify

Verified Analysis

We value integrity, quality and authenticity the most.

© 2025 Virtue Market Research. All Rights Reserved.